Skip to main content
. 2019 May 31;27(9):1475–1480. doi: 10.1038/s41431-019-0430-5

Table 1.

Candidate gene variants detected by whole-exome sequencing

Chr Position Gene Transcript accession# Exon Nucleotide change Amino acid change ExAc Gnomad CADD
De novo
 9 39103792 CNTNAP3 NM_033655.3 16 c.2485G > C p.(Val829Leu) −1 −1 23.4
 2 202251090 TRAK2 NM_015049.2 14 c.1814A > C p.(Tyr605Ser) −1 −1 29.4
 11 86947710 TMEM135 NM_022918.3 6 c.494_498del p.(Tyr165fs) −1 −1
Homozygous
 3 127323612 MCM2 NM_004526.2 3 c.398G > A p.(Arg133His) 0.003 0.0018 27
X-linked
 X 47060300 UBA1 NM_003334.3 6 c.488T > C p.(Val163Ala) −1 −1 25.5

WES was performed on the trio by SureSelect Clinical Research Exome (Agilent, Technologies) and NextSeq500 sequencing system (Illumina, hg 19 human reference genome). A customized pipeline based on Burrows-Wheeler Alignment tool, Genome Analysis Toolkit and ANNOVAR were used to call, annotate, filter, and prioritize variants. Variants are submitted in LOVD repository (as Lab-ID ULOele-15-22; https://databases.lovd.nl/shared/individuals/00228899).

−1: indicate absence in control dataset. Additional interpretation of these variants is provided in Supplementary material

Chr chromosome, ExAC Exome Aggregation Consortium, Gnomad Genome Aggregation Database, CADD Combined Annotation Dependent Depletion